Corante

About this author
Zack Lynch is author of The Neuro Revolution: How Brain Science Is Changing Our World (St. Martin's Press, July 2009).
He is the founder and executive director of the Neurotechnology Industry Organization (NIO) and co-founder of NeuroInsights. He serves on the advisory boards of the McGovern Institute for Brain Research at MIT, the Center for Neuroeconomic Studies, Science Progress, and SocialText, a social software company. Please send newsworthy items or feedback - to Zack Lynch.
Follow me on Twitter at @neurorev
Receive by email

GUEST AUTHOR ARCHIVES
THE NEURO REVOLUTION
TNRCoverWeb120.jpg Buy on Amazon
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

Brain Waves

« Empathy in the Brain and in Art | Main | Happiness Defined by Thomas Jefferson »

December 28, 2004

Home Again: Duo to PC to G4

Email This Entry

Posted by Zack Lynch

Two months ago I switched back to Apple. Having gone through 5 PC laptops over 8 years, the last three all IBM thinkpads (read the pain here, here), I took the sage advice of Ross, Matt, Dan, Kevin, Steven, and all the other powerbook users I know and trust. I haven't been this happy with information technology in years.

The last piece of the transition was finished yesterday when Craigslist brought Mike Slavko into my life who came to my house and transferred my decade old files from my Apple Duo to my G4. I highly recommend Mike if you have Apple issues (which are few and far between).

Comments (0) + TrackBacks (0) | Category: X-tra



EMAIL THIS ENTRY TO A FRIEND

Email this entry to:

Your email address:

Message (optional):




RELATED ENTRIES
Neurotech 2010: Translational Researchers Highlight Innovation
The Neuro Revolution in China Progressing
Speakers for Neurotech 2010 - Boston, May 19-20
Giving the Brain a Voice: NIO Public Policy Tour in DC tomorrow
McGovern Institue for Brain Research at MIT Goes Web 2.0
The Neurodiagnostics Report 2010: Brain Imaging, Biomarkers and NeuroInformatics
Neuropharma FDA Approvals Down in 2009
Tel Aviv Neurotech Cluster Thrives